Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Novartis
Jemincare
Pfizer
Sirtex Medical
VA Office of Research and Development
Pfizer
Celgene
Xoft, Inc.
AstraZeneca
Cytori Therapeutics
National Institutes of Health Clinical Center (CC)